Blog Archives

Sudler New York Announces the Prescribed Products Promotional Standards Distribution

Sudler is pleased to announce an initiative to create Open Source standardized website safety information components that are FDA compliant, responsive, and semantically-optimized to comply with both the FDA’s microdata format and Google’s Knowledge Graph requirements. The ‘Rx Promotional Standards Distribution’ will leverage Drupal and the Acquia Cloud platform to deliver significant operational efficiencies to [...]

Posted in FDA Guidance, Leadership, Marketing, Mobile, Technology, Thoughts | Leave a comment
Share |

FDA Issues New Draft Guidance Documents

Our colleagues at Dose of Digital have assembled two sets of key takeaways from Tuesday’s draft guidance documents on “Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation about prescription Drugs and Medical Devices” and “Internet/Social Media Limitations – Presenting Risk And Benefit Information for Prescription Drugs and Medical Devices”. The examples provided in the draft documents [...]

Posted in FDA Guidance, Social Media, Thoughts | Leave a comment
Share |

FDA Starting to Issue Social Media Guidelines

It seems that Monday’s release of submission guidelines is actually the first in a series of releases from the FDA that will address the issues raised in the 2009 Social Media public hearings. Our friends at Dose of Digital were quick off the mark with some analysis of the guidance, which is a worthwhile read [...]

Posted in FDA Guidance, Leadership, Marketing, News, Social Media, Thoughts | Leave a comment
Share |

Are Meta Tags a Regulatory Time Bomb?

Andy Bond, Sudler’s head of Digital Strategy, examines the current state of regulations and recommendations around how pharma brand sites should approach their meta tags in his post on Dose of Digital.

Posted in FDA Guidance, Marketing, SEO, Thoughts | Leave a comment
Share |

Will Penguin Freeze Out Pharma?

Sudler’s Director of Technology is concerned that Google’s latest search algorithm update (Penguin) may impact the rankings of pharma brand sites, given the common requirement that we repeat the full Safety Information on every page. In his Dose of Digital article, he examines the history of the SEO industry, Google’s recommendations, and some possible solutions.

Posted in FDA Guidance, SEM, SEO, Technology, Thoughts | Leave a comment
Share |

FDA Social Media Guidance Released

The FDA has finally released their guidance on Pharma’s use of social media (from the November 2009 hearings), and our friend at Dose of Digital have created a neat flowchart and summary of the guidance. Invaluable reading…

Posted in Creative, DDMAC, FDA Guidance, Marketing, News, Social Media, Thoughts, Twitter, YouTube | Leave a comment
Share |

DDMAC says, “Follow the Regs”

In yet another indication that industry and agencies should not expect major changes in social media marketing rules, Tom Abrams, the head of FDA’s Division of Drug Marketing, Advertising, and Communications (DDMAC), told participants at DIA’s annual marketing meeting in Washington, D.C., on Feb. 22 to “follow the regulations” while waiting for formal FDA guidance. [...]

Posted in DDMAC, FDA Guidance, Social Media, Thoughts | Leave a comment
Share |

FDAsm

Follow everything social about the FDA social media hearings at FDAsm. Hashtag: #fdasm. UPDATE: You’ll also find the presentation testimony, FDA updates on the lack of updates, and tweets galore.

Posted in FDA Guidance, Social Media, Thoughts | Leave a comment
Share |